Scientists Question Data Behind an Experimental Alzheimer’s Drug

Written by

APOORVA MANDAVILLI

in

Studies linked to Cassava Sciences, once a stock market favorite, have been retracted or challenged by medical journals.

Author: APOORVA MANDAVILLI

Academic and Scientific Journals Alzheimer’s Disease Biotechnology and Bioengineering Cassava Sciences Inc Clinical Trials Drugs (Pharmaceuticals) Elderly Journal of Alzheimer’s Disease Journal of Neuroscience Short Selling United States your-feed-science

Comments

Leave a ReplyCancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

More posts